Journal
Translational Lung Cancer Research
Publication Date
7-1-2022
Volume
11
Issue
7
First Page
1468
Last Page
1478
Document Type
Open Access Publication
DOI
10.21037/tlcr-22-476
Rights and Permissions
Zhao D, Xu L, Wu J, She Y, Su H, Hou L, E H, Zhang L, Grossi F, Subramanian MP, Kim AW, Zhu Y, Chen C. Comparison of perioperative outcomes among non-small cell lung cancer patients with neoadjuvant immune checkpoint inhibitor plus chemotherapy, EGFR-TKI, and chemotherapy alone: a real-world evidence study. Transl Lung Cancer Res. 2022 Jul;11(7):1468-1478. doi: 10.21037/tlcr-22-476. © Translational Lung Cancer Research. All rights reserved. Attribution-Non Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0).
Recommended Citation
Zhao, Deping; Xu, Long; Wu, Junqi; She, Yunlang; Su, Hang; Hou, Likun; E., Haoran; Zhang, Lei; Grossi, Francesco; Subramanian, Melanie P.; Kim, Anthony W.; Zhu, Yuming; and Chen, Chang, "Comparison of perioperative outcomes among non-small cell lung cancer patients with neoadjuvant immune checkpoint inhibitor plus chemotherapy, EGFR-TKI, and chemotherapy alone: A real-world evidence study." Translational Lung Cancer Research. 11, 7. 1468 - 1478. (2022).
https://digitalcommons.wustl.edu/oa_4/199
